维普期刊资源整合服务平台（V6.5）

48篇 您的检索式：作者名="Greulich H"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	EGFR mutations in hmg cancer: Correlation with clinical response to gefitinib therapy 显示文摘	Paez JG Janne PA Lee JC Traey S Greulich H Gabriel S el al	2004	Science2004，304，4：	1
2	Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-smallcell lung cancer-associated mutations of the epidermal growth factor receptor显示文摘	Alvarez JV Greulich H Sellers WR	2006	Cancer Res2006，66，6：	1
3	Oncogcnic transformation by inhibitor-sensitive and -resistant EGFR mutants 显示文摘	Greulich H Chcn TH Feng W	2005	Plos Med2005，，：	1
4	Similarities of the biological activities of coronatine and coronafacic acid to those of jasmonic acid显示文摘	KODA Y TAKAHASHI K KIKUTA Y GREULICH F TOSHIMA H ICHIHARA A	1996	Phytochemistry1996，41，1：	1
5	Oncogenic transformation by inhibitor-sensitive and-resistant EGFR mutants显示文摘	Greulich H Chen TH Feng W	2005	PLoS Med2005，2，11：	1
6	Oncogenic transformation by inhibitor-sensitive and-resistant EGFR mutants显示文摘	Greulich H Chen TH Feng W		0，，：	1
7	EGFR mutations in lung cancer:correlation with clinical response to gefitinib therapy显示文摘	Paez JG Janne PA Lee JC Tracy S Greulich H Gabriel S		0，，5676：	1
8	Tbxl8function in epicardial development显示文摘	Greulich F Farin H F Schuster-Gossler K	2012	Cardiovasc Res2012，96，3：	1
9	Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor(EGFR)expression and sensitizes EGFR mutant tumors to paclitaxel显示文摘	Sawai A Chandarlapaty S Greulich H	2008	Cancer Res2008，68，2：	1
10	Targeting mutant fibroblastgrowth factor receptors in cancer显示文摘	GREULICH H POLLOCK P M	2011	Trends Mol Med2011，17，5：	1
11	Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor 显示文摘	Alvarez J V Greulich H Sellers W R Meyerson M Frank D A	2006	Cancer Res2006，66，：	1
12	Oncogenic transformation by inhibitor-sensitive and-resistant EGFR mutants显示文摘	GREULICH H CHEN T-H FENG W		0，，11：	1
13	Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor显示文摘	Alvarez JV Greulich H Sellers WR	2006	Cancer Res2006，66，6：	1
14	Oncogenic transformation by inhibitor-sensitive and -resistant EGFR mutants 显示文摘	Greulich H Chen TH Feng W	2005	PLoS Med2005，2，：	1
15	Inhibition of Hsp90 down-regulates mutant epidermal growth factor receptor (EGFR) expression and sensitizes EGFR mutant tumors to paclitaxel显示文摘	Sawai A Chandarlapaty S Greulich H	2008	Cancer Res2008，68，2：	1
16	Signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor显示文摘	Alvarez J V Greulich H Sellers W R	2006	Cancer Res2006，66，6：	1
17	Signaltransducer and activator of transcription 3 is required forthe oncogenic effects of non-small cell lung cancer-associated mutations of the epidermal growth factorreceptor显示文摘	Alvare JV Greulich H Sellers WR	2006	Cancer Res2006，66，6：	1
18	signal transducer and activator of transcription 3 is required for the oncogenic effects of non-small-cell lung cancer-associated mutations of the epidermal growth factor receptor显示文摘	Alvarez JV Greulich H Sellers WR		0，，06：	1
19	Oncogenic transformation by inhibitor-sensitive and-resistant EGFR mutants显示文摘	Greulich H Chen TH Feng W	2005	PLoS Med2005，2，11：	1
20	The role of epicardial and perivascular adipose tissue in the pathophysiology of cardiovascu- lar disease显示文摘	Ouwens D M Sell H Greulich S	2010	J Cell Mol Med2010，14，9：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示